Skip to main content
. 2018 Oct 8;11:1756284818802562. doi: 10.1177/1756284818802562

Appendix 2.

Model parameters used fin probabilistic analysis.

Parameters Mean SD distribution alpha beta
Probabilities
PTNS ⩾50% improvement 0.6200 0.0300 beta 161.6822 99.0956
Proceeding to permanent SNS 0.7350 0.1500 beta 5.6277 2.0290
SNS_⩾50% improvement 0.7750 0.0350 beta 109.5439 31.8031
Adverse events for temporary SNS 0.2039 0.0828 beta 4.6281 18.0740
Adverse events for permanent SNS 0.2487 0.0625 beta 11.6484 35.1864
QALY
PTNS ⩾50% improvement 3.3743 0.5087 normal 44.0037 13.0407
PTNS discontinued 2.8793 0.3233 normal 79.3048 27.5434
Temporary SNS_adverse_no_implant 2.8710 0.3191 normal 80.9752 28.2043
QALY_TempSNS_no_adverse_no_implant 2.8793 0.3233 normal 79.3048 27.5434
QALY_PermSNS_adverse2_improved 3.3579 0.4989 normal 45.3080 13.4931
QALY_PermSNS_adverse2_not_improved 2.8628 0.3148 normal 82.6991 28.8878
QALY_PermSNS_adverse1_improved 3.3743 0.5087 normal 44.0037 13.0407
QALY_PermSNS_adverse1_not_improved 2.8710 0.3191 normal 80.9752 28.2043
QALY_PermSNS_no_adverse_not_improved 2.8793 0.3233 normal 79.3048 27.5434
QALY_PermSNS_no_adverse_improved 3.3743 0.5087 normal 44.0037 13.0407
Costs PTNS
⩾50% improvement 4,040.61 715.54 gamma 31.8881 0.0079
No improvement 2,364.21 422.01 gamma 31.3860 0.0133
Discontinued 607.49 30.62 gamma 393.7170 0.6481
Costs SNS
Temporary SNS, no adverse events 1,562.94 190.97 gamma 66.9787 0.0429
Temporary SNS, adverse events 2,229.23 358.08 gamma 38.7578 0.0174
Permanent SNS, no adverse events, ⩾50% improvement 14,103.89 2,525.38 gamma 31.1906 0.0022
Permanent SNS, no adverse events, no improvement 13,267.37 2,363.65 gamma 31.5067 0.0024
Temporary SNS with adverse events + permanent SNS with adverse events, ⩾50% improvement 18,150.79 3,898.14 gamma 21.6808 0.0012
Temporary SNS with adverse events + permanent SNS with adverse events, no improvement 17,314.27 3,736.41 gamma 21.4733 0.0012
Temporary SNS with adverse events + permanent SNS no adverse events, ⩾50% improvement 14,770.18 2,692.45 gamma 30.0937 0.0020
Temporary SNS with adverse events + permanent SNS no adverse events, no improvement 13,933.66 2,530.72 gamma 30.3140 0.0022
Temporary SNS no adverse events + permanent SNS with adverse events, ⩾50% improvement 17,484.51 3,731.08 gamma 21.9603 0.0013
Temporary SNS no adverse events + permanent SNS with adverse events, no improvement 16,647.98 3,569.34 gamma 21.7544 0.0013
Costs PTNS+SNS
PTNS + temporary SNS, no adverse events 3,927.15 521.86 gamma 56.6305 0.0144
PTNS + temporary SNS, adverse events 4,593.44 643.92 gamma 50.8871 0.0111
PTNS + permanent SNS, no adverse events, ⩾50% improvement 16,468.11 2,697.60 gamma 37.2677 0.0023
PTNS + permanent SNS, no adverse events, no improvement 15,631.58 2,537.74 gamma 37.9412 0.0024
PTNS + temporary SNS with adverse events + permanent SNS with adverse events, ⩾50% improvement 20,515.01 4,060.83 gamma 25.5219 0.0012
PTNS + temporary SNS with adverse events + permanent SNS with adverse events, no improvement 19,678.49 3,899.93 gamma 25.4607 0.0013
PTNS + temporary SNS with adverse events + permanent SNS no adverse events, ⩾50% improvement 17,134.39 2,863.45 gamma 35.8063 0.0021
PTNS + temporary SNS with adverse events + permanent SNS no adverse events, no improvement 16,297.87 2,703.40 gamma 36.3447 0.0022
PTNS + temporary SNS no adverse events + permanent SNS with adverse events, ⩾50% improvement 19,848.72 3,894.26 gamma 25.9786 0.0013
PTNS + temporary SNS no adverse events + permanent SNS with adverse events, no improvement 19,012.20 3,733.41 gamma 25.9331 0.0014